United States Supreme Court
Association for Molecular Pathology v. Myriad Genetics, Inc., 12-398
A naturally occurring DNA segment is a product of nature and not patent eligible merely because it has been isolated, but cDNA, whose creation results in an exons-only molecule, is patent eligible because it is not naturally occurring.
Appellate Information
- Decided 06/13/2013
- Published 06/13/2013
Judges
- THOMAS
Court
- United States Supreme Court